AbbVie
ABBV
$191.08
Share price
-0.70%
Change (1 day)
12.61%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Stock price history for AbbVie (ABBV)
Highest end of day price: $216.66 USD on 2025-03-10
Lowest end of day price: $33.71 USD on 2013-01-08
Stock price history of AbbVie from 2013 to 2025
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2025 | 6.49% |
| 2024 | 11.19% |
| 2023 | -4.56% |
| 2022 | 19.34% |
| 2021 | 28.45% |
| 2020 | 19.65% |
| 2019 | -0.77% |
| 2018 | -6.32% |
| 2017 | 54.96% |
| 2016 | 8.70% |
| 2015 | -10.09% |
| 2014 | 25.89% |
| 2013 | 50.37% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Pfizer PFE | $24.54 | -1.21% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $49.75 | -1.85% | 🇺🇸 USA |
 Eli Lilly LLY | $819.36 | 0.90% | 🇺🇸 USA |
 Amgen AMGN | $295.22 | -0.70% | 🇺🇸 USA |
 Gilead Sciences GILD | $109.98 | -1.15% | 🇺🇸 USA |
 Biogen BIIB | $130.65 | -1.25% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $40.86 | -3.84% | 🇬🇧 UK |
 AstraZeneca AZN | $74.42 | -0.77% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $124.39 | -0.50% | 🇺🇸 USA |